Skip to content

Clinical study on Percutaneous Acupoint Electrical Stimulation on patients with hypertension complicated with insomnia disorder

Clinical study on Percutaneous Acupoint Electrical Stimulation on patients with hypertension complicated with insomnia disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078509
Enrollment
Unknown
Registered
2023-12-11
Start date
2023-12-12
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with high normal blood pressure or hypertension complicated with insomnia disorder

Interventions

percutaneous acupoint electrical stimulation + conventional treatment:percutaneous acupoint electrical stimulation + conventional treatment

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: ? Age =18 years old, male or female; ? Meet the diagnostic criteria for high normal blood pressure or hypertension, and the subject's blood pressure in the resting room is =159/99mmHg; ? PSQI>5 points; ? Speechless and intellectual disability, can successfully answer and fill in the questionnaire; ? Seek the consent of the patient or his/her guardian and be willing to participate.

Exclusion criteria

Exclusion criteria: ? Contraindications for the use of acupoint stimulators: patients with cardiac pacemakers and other implanted medical devices; Suffering from acute diseases, infectious diseases, malignant tumors and other serious cardiovascular and cerebrovascular diseases, liver and kidney insufficiency or other malignant diseases; There are scars, bruises, scratches or inflammation on the skin of the acupoints; ? Other sleep disorders, including restless legs or periodic limb movements during sleep (number of periodic limb movements per hour >15), circadian rhythm disturbance, rapid eye movement behavior disorder, narcolepsy, etc.; A lifetime history of any sleep-related breathing disorders, including chronic obstructive pulmonary disease and sleep apnea (apnea/hypopnea index); ?Have night work or irregular sleep patterns, and are unable or unwilling to stop this pattern of work; ? Hypertension caused by renal parenchymatous hypertension, renal artery stenosis and other vascular diseases, primary aldosteronism and other endocrine hypertension, and secondary hypertension caused by other causes; ?Have taken medications other than blood pressure medications in the past 4 weeks that may cause sleep disturbances: such as steroid medications; ?Have received acupuncture or other similar physiotherapy techniques in the past month; ?Suspected or have a history of alcohol and drug abuse; ? Pregnant women, women of childbearing age who have not used contraceptives, women during pregnancy and breastfeeding; ? Uncontrolled diabetes; ? Patients who have participated in other clinical trials within the last 1 month; Those who meet one or more of the above requirements will be excluded.

Design outcomes

Primary

MeasureTime frame
Response rate (blood pressure);PSQI score;

Secondary

MeasureTime frame
Systolic blood pressure;Diastolic blood pressure;GAD-7 score;

Countries

China

Contacts

Public ContactWang Liqiong

Beijing University of Chinese Medicine

wangliqiongwork@163.com+86 185 1175 5226

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026